441 related articles for article (PubMed ID: 33507515)
41. Treatment options for mantle cell lymphoma.
Smolewski P; Witkowska M; Robak T
Expert Opin Pharmacother; 2015; 16(16):2497-507. PubMed ID: 26360791
[TBL] [Abstract][Full Text] [Related]
42. Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma.
Lymphoma Research Foundation LRF
Oncology (Williston Park); 2024 Feb; 38(2):51-67. PubMed ID: 38421601
[TBL] [Abstract][Full Text] [Related]
43. Bruton tyrosine kinase inhibitors for the treatment of mantle cell lymphoma: review of current evidence and future directions.
Bond DA; Alinari L; Maddocks K
Clin Adv Hematol Oncol; 2019 Apr; 17(4):223-233. PubMed ID: 31188814
[TBL] [Abstract][Full Text] [Related]
44. Update on mantle cell lymphoma.
Maddocks K
Blood; 2018 Oct; 132(16):1647-1656. PubMed ID: 30154113
[TBL] [Abstract][Full Text] [Related]
45. Recent advances and future directions in mantle cell lymphoma research: report of the 2018 mantle cell lymphoma consortium workshop.
Kahl BS; Dreyling M; Gordon LI; Martin P; Quintanilla-Martinez L; Sotomayor EM
Leuk Lymphoma; 2019 Aug; 60(8):1853-1865. PubMed ID: 30696305
[TBL] [Abstract][Full Text] [Related]
46. Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network.
Dreyling M; Amador V; Callanan M; Jerkeman M; Le Gouill S; Pott C; Rule S; Zaja F;
Leuk Lymphoma; 2015 Apr; 56(4):866-76. PubMed ID: 25015778
[TBL] [Abstract][Full Text] [Related]
47. ADCs, BiTEs, CARs, and Small Molecules: A New Era of Targeted Therapy in Non-Hodgkin Lymphoma.
Abramson JS; Ghosh N; Smith SM
Am Soc Clin Oncol Educ Book; 2020 May; 40():302-313. PubMed ID: 32421455
[TBL] [Abstract][Full Text] [Related]
48. Novel targeted therapeutics for mantle cell lymphoma--what's on the horizon?
El Halabi L; Ghez D; Ribrag V
Expert Rev Hematol; 2016 Mar; 9(3):271-81. PubMed ID: 26689790
[TBL] [Abstract][Full Text] [Related]
49. Ibrutinib for the treatment of mantle cell lymphoma.
Shah N; Hutchinson C; Rule S
Expert Rev Hematol; 2014 Oct; 7(5):521-31. PubMed ID: 25158606
[TBL] [Abstract][Full Text] [Related]
50. Current status of targeted therapies for mantle cell lymphoma.
Chang JE; Kahl BS
Drugs; 2011 Dec; 71(17):2307-26. PubMed ID: 22085387
[TBL] [Abstract][Full Text] [Related]
51. Mantle cell lymphoma - advances in molecular biology, prognostication and treatment approaches.
Silkenstedt E; Linton K; Dreyling M
Br J Haematol; 2021 Oct; 195(2):162-173. PubMed ID: 33783838
[TBL] [Abstract][Full Text] [Related]
52. SOHO State of the Art Updates and Next Questions: Managing Relapsed Mantle Cell Lymphoma.
Romancik JT; Gerber DG; Zhuang T; Cohen JB
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):557-565. PubMed ID: 35123927
[TBL] [Abstract][Full Text] [Related]
53. The current therapeutic scenario for relapsed mantle cell lymphoma.
Ferrero S; Dreyling M
Curr Opin Oncol; 2013 Sep; 25(5):452-62. PubMed ID: 23872784
[TBL] [Abstract][Full Text] [Related]
54. Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop.
Gordon LI; Bernstein SH; Jares P; Kahl BS; Witzig TE; Dreyling M
Leuk Lymphoma; 2014 Oct; 55(10):2262-70. PubMed ID: 24512319
[TBL] [Abstract][Full Text] [Related]
55. Mantle cell lymphoma-Update on molecular biology, prognostication and treatment approaches.
Silkenstedt E; Dreyling M
Hematol Oncol; 2023 Jun; 41 Suppl 1():36-42. PubMed ID: 37294961
[TBL] [Abstract][Full Text] [Related]
56. Mantle cell lymphoma: report of the 2009 Mantle Cell Lymphoma Consortium Workshop.
Williams ME; Dreyling MH; Kahl BS; Leonard JP; O'Connor OA; Press OW; Wilson WH
Leuk Lymphoma; 2010 Mar; 51(3):390-8. PubMed ID: 20038219
[TBL] [Abstract][Full Text] [Related]
57. Therapies for mantle cell lymphoma: current challenges and a brighter future.
Skarbnik AP; Smith MR
Discov Med; 2013 Mar; 15(82):177-87. PubMed ID: 23545046
[TBL] [Abstract][Full Text] [Related]
58. Current management of mantle cell lymphoma.
Weigert O; Unterhalt M; Hiddemann W; Dreyling M
Drugs; 2007; 67(12):1689-702. PubMed ID: 17683170
[TBL] [Abstract][Full Text] [Related]
59. Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.
Williams ME; Connors JM; Dreyling MH; Gascoyne RD; Kahl BS; Leonard JP; Press OW; Wilson WH
Leuk Lymphoma; 2011 Jan; 52(1):24-33. PubMed ID: 21133727
[TBL] [Abstract][Full Text] [Related]
60. Mantle cell lymphoma: are current therapies changing the course of disease?
Geisler C
Curr Oncol Rep; 2009 Sep; 11(5):371-7. PubMed ID: 19679012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
